Delivery Order HHSN261201500037I-HHSN26100001
Award Date
9/22/15
Potential Completion Date
12/31/15
Potential Value
$3.6K
Federal Agency
National Cancer Institute
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Milwaukee, WI 53226, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
8
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $460,975.01 firm fixed-price delivery order awarded by the National Institutes of Health (NIH) National Cancer Institute to The Medical College of Wisconsin, Inc. (MCW), a private medical school and graduate institution. The contract is part of the NIH's "PREVENT Cancer Program (PREVENT)" and supports the "Preclinical Prevent Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers" major program. No set-aside designation was used. Through past...
This is a Firm Fixed Price Delivery Order award under the National Cancer Institute's PREVENT Cancer Program Indefinite Delivery Contract (HHSN261201500037I). The prime contractor is The Medical College Of Wisconsin, Inc. (MCW), a private non-profit medical research institution. The award, valued at $598,803.88, is for examination of exosomal miRNAs as potential biomarkers for chemopreventive efficacy in mouse models of lung squamous cell carcinoma. This work will be performed by MCW from...
The Medical College of Wisconsin, Inc. was awarded a firm fixed price delivery order valued at six hundred twenty-nine thousand one hundred fifteen dollars and seventy cents ($629,115.70) by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. The delivery order was issued against the PREVENT Cancer Program master indefinite-delivery/indefinite-quantity contract vehicle to support the PRECLINICAL PREVENT CANCER...
The U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a $374,879 firm fixed price delivery order to The Medical College of Wisconsin, Inc. (MCW) to develop a multi-antigen, multi-peptide vaccine. The period of performance was September 15, 2017 to November 14, 2018. This award was for the Preclinical Prevent Cancer Program, which focuses on preclinical efficacy and intermediate endpoint biomarkers. MCW is a private medical school and...
The Medical College of Wisconsin, Inc. was awarded a firm fixed price delivery order against the PREVENT Cancer Program (PREVENT) master indefinite delivery/indefinite quantity contract to provide research services for Lung Cancer Chemoprevention by MicroRNA Delivery. The $377,589.48 potential value contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute on September 1, 2016, with an anticipated completion date of August 31,...
The Medical College of Wisconsin, Inc. was awarded a $633,080.38 delivery order against the PREVENT Cancer Program master IDIQ contract to develop multiantigen vaccines preventing lung adenocarcinomas driven by K-Ras or EGFR oncoproteins in mice. The National Cancer Institute, part of the Department of Health and Human Services, issued the award under its PRECLINICAL PREVENT CANCER PROGRAM focused on preclinical efficacy and intermediate endpoint biomarkers. Performance will occur in...
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to The Medical College of Wisconsin, Inc. (MCW) on March 10, 2010. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ and has a ceiling value of $64,452.68. The purpose is to obtain tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which was funded under the American Recovery and Reinvestment Act...
This is a Firm Fixed Price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to the University of Alabama at Birmingham (UAB) under the PREVENT Cancer Program (PREVENT) indefinite delivery contract. The contract has a ceiling value of $922,642.00 and no set-aside designation. The contract describes a research and development project in the area of biomedical basic research for the Preclinical Prevention Cancer Program. The work involves conducting preliminary...
This federal contract award was issued by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to The Institute for Cancer Research, a non-profit organization and subsidiary of Temple University. The $1,570,991.00 task order is part of the PREVENT Preclinical Drug Development Program, which focuses on preclinical efficacy and intermediate endpoint biomarker testing for cancer prevention drug candidates. The task order is for a project titled...
This is a $2,453,803.00 delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to the University of Wisconsin System for the "CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH". The contract is part of the larger "Cancer Prevention Agent Development Program 2012-2017" contract vehicle and is for cost-no-fee work. The contract does not have a set-aside designation and is...